Ignite Creation Date:
2024-07-17 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06480110
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2020-11-18
Brief Title:
Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer
Sponsor:
Rigshospitalet Denmark
Organization:
Rigshospitalet Denmark
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Castration-resistant Prostate Cancer |
Keywords: